Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

The deal focuses on a weight-loss pill in development at YaoPharma, a GLP-1 agonist codenamed YP05002, which is currently in ...

Pfizer's oral HER2 inhibitor Tukysa looks poised to find a new role as first-line maintenance therapy for HER2-positive ...

The results of the lidERA trial in patients with HR-positive, HER2-negative early breast cancer – previewed last month and ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

Chambers discusses her personal experience as a GP in the NHS, including the discrimination she faced as a woman, and ...

Today, the EU Council and Parliament reached an agreement in principle on the long-awaited pharma reform package, but ...

In September, Takeda announced that it is making pharma history – becoming the first in the industry to ship medicines across ...

Menopause is another major area. “Many women can’t tolerate oral progesterone. If they’re on oestrogen and have a uterus, ...

The other new piece to MFN in its current incarnation is the direct-to-patient platform TrumpRX, and the promise that MFN ...

Artificial intelligence (AI) is reshaping industries across the board, but nowhere are the stakes higher than in life ...

According to researchers, medical training has reached a stage where students know more, but understand less. Although there ...